 |
HAL Université des Antilles |  |
In silico development of novels radiopharmaceuticals for positron emission tomography from inhibitors of mechanistic target of rapamycin (MTOR)
A. Ferino-Perez
Fritz-Line Velayoudom Cephise
1
L. Belia
Sarra Gaspard
2
Ulises Javier Jáuregui Haza
3
A. Ferino-Perez
Author
Fritz-Line Velayoudom Cephise 1
Author
L. Belia
Author
Sarra Gaspard 2
Mail :
Author
Ulises Javier Jáuregui Haza 3
Author
1
Equipe de recherche sur le Risque Cardio métabolique (France)
- UAG - Université des Antilles et de la Guyane (Fouillole - BP 250 - 97157 Pointe-à-Pitre - Guadeloupe)
2
UA - Université des Antilles (Université des Antilles | Fouillole - BP 250 - 97157 Pointe-à-Pitre - France)
Document type :
Poster communications
Complete list of metadatas
https://hal.univ-antilles.fr/hal-02425017
Contributor : Olivier Gros <>
Submitted on : Sunday, December 29, 2019 - 1:30:37 PM
Last modification on : Friday, January 24, 2020 - 7:42:14 PM
Contributor : Olivier Gros <>
Submitted on : Sunday, December 29, 2019 - 1:30:37 PM
Last modification on : Friday, January 24, 2020 - 7:42:14 PM
Identifiers
- HAL Id : hal-02425017, version 1
Citation
A. Ferino-Perez, Fritz-Line Velayoudom Cephise, L. Belia, Sarra Gaspard, Ulises Javier Jáuregui Haza. In silico development of novels radiopharmaceuticals for positron emission tomography from inhibitors of mechanistic target of rapamycin (MTOR). Caribbean Science and Innovation Meeting 2019, Oct 2019, Pointe-a-Pitre (Guadelupe), France. ⟨hal-02425017⟩
Metrics
Record views
